PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

15 registration certificates of medicines have been withdrawn from the State Register

The Ministry of Health of the Russian Federation has revoked registration certificates for 15 drugs based on applications from their owners. Of these, 13 belonged to JSC Pharmstandard-Tomskkhimpharm, the rest belonged to JSC Sanofi Russia. Information about this appeared on the GRLS website.

Recalled drugs of JSC Pharmstandard-Tomskkhimpharm: 

“Ethyl alcohol” ((ethanol), LSR-008197/08 dated 10/16/2008);

“Citramon P” (LSR-000021 dated 03/28/2007);

“Furosemide” ((furosemide) LS-000488 dated 11/18/2009);

Prednisone (prednisone) LSR-003276/07 dated 10/17/2007);

“Paracetamol” ((paracetamol) LSR-000062 dated 05/10/2007);

Pantocrine (LSR-003253/07 dated 17.10.2007);

“Nitrosorbide” ((isosorbide dinitrate) LSR-003429/07 dated 10/26/2007);

Peppermint tincture (LSR-003434/07 dated 10/26/2007);

“Levomycetin” ((chloramphenicol) LS-001979 dated 07/9/2010);

“Potassium orotate” ((orotic acid) LSR-003254/07 dated 17.10.2007);

Hawthorn tincture (LS-002044 from 08/25/2009);

“Acetylsalicylic acid” ((acetylsalicylic acid) R N003094/01 dated 12/15/2008);

“Analgin” ((sodium metamizole), P N001244/01 dated 01/23/2008).

Recalled drugs of Sanofi Russia JSC:

“Troxerutin Sanofi” ((troxerutin) N N015161/01 dated 08/13/2008);

“Tritatse” ((ramipril) LSR-008998/09 dated 09.11.2009).

All drugs excluded from the GRLS have registered analogues on the Russian market.

Current news

  • March 10, 2026

    Public Procurement of Medicines in Russia Reached 1 Trillion Rubles in 2025

    Public procurement of medicines in Russia totaled 1 trillion rubles in 2025, representing a 26%…

  • March 10, 2026

    Retail Pharmaceutical Market Value Increased by 13.3% in 2025

    The value of Russia’s retail pharmaceutical market reached 1.83 trillion rubles in 2025, marking a…

  • March 10, 2026

    New Molecules Synthesized in Russia for Next-Generation Medicines

    The compounds could help develop antimicrobial, anticancer, and anti-inflammatory drugs, according to the press service…

  • March 10, 2026

    DSM Group Presents Top 10 Russian Pharmaceutical Distributors

    According to data from DSM Group, the pharmaceutical market volume at distributor prices reached 2.87…

  • March 10, 2026

    Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030

    The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную…

LLC “BioJet”. all rights reserved

  • Legal information